Clinical course of IPF in Italian patients during 12 months of observation: results from the FIBRONET observational study

Respiratory Research

G. Crespi¹  B. Campolo¹  S. Harari²  V. Poletti³  R. R. Metella⁴  S. Rizzoli⁵  A. Pesci⁶  C. Vancheri⁷  C. Albera⁸ 

[1] Boehringer Ingelheim, Milan, Italy;Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy;Department of Medicine, Ospedale San Giuseppe MultiMedica IRCCS, Milan, Italy;Department of Diseases of the Thorax, Ospedale GB Morgagni, Forlì, Italy;Department of Respiratory Diseases & Allergy, Aarhus University Hospital, Aarhus, Denmark;Dipartimento di Scienze Mediche Chirurgiche e Neuroscienze, Università degli Studi di Siena, Siena, Italy;MediNeos Observational Research, Modena, Italy;Ospedale San Gerardo, ASST Monza, Monza, Italy;Regional Referral Centre for Rare Lung Diseases—University Hospital “Policlinico G. Rodolico”, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy;S.C. Pneumologia U., A.O.U. Città Della Scienza E Della Salute (Molinette), University of Torino, Torino, Italy;

关键词: Idiopathic pulmonary fibrosis;    Real-world;    Observational;    Italy;    Antifibrotic therapy;    Nintedanib;    Pirfenidone;    Lung function;   

DOI  :  10.1186/s12931-021-01643-w

来源: Springer

【 授权许可】

CC BY